share_log

CVS Health | DEFA14A: Others

CVS Health | DEFA14A: Others

西維斯健康 | DEFA14A:其他
SEC announcement ·  04/06 04:10
牛牛AI助理已提取核心訊息
CVS Health Corporation has announced its 2024 Annual Meeting of Stockholders, scheduled to be held virtually on May 16, 2024. Stockholders are encouraged to vote in advance of the meeting, with a deadline for voting set at May 15, 2024, 11:59 P.M., ET. The meeting will address several key proposals, including the election of directors, ratification of the independent registered public accounting firm for 2024, advisory approval of executive compensation, and amendments to the incentive compensation plan. Additionally, stockholders will consider proposals regarding worker rights assessment, director re-nomination criteria, policies on golden parachutes, and director time allocation disclosure. The board recommends voting for the election of all director nominees and most proposals but advises against proposals related to worker rights assessment, director re-nomination, golden parachutes, and director time allocation disclosure. Stockholders can access meeting materials and vote online at www.ProxyVote.com, with options to request paper or email copies of the materials by May 2, 2024.
CVS Health Corporation has announced its 2024 Annual Meeting of Stockholders, scheduled to be held virtually on May 16, 2024. Stockholders are encouraged to vote in advance of the meeting, with a deadline for voting set at May 15, 2024, 11:59 P.M., ET. The meeting will address several key proposals, including the election of directors, ratification of the independent registered public accounting firm for 2024, advisory approval of executive compensation, and amendments to the incentive compensation plan. Additionally, stockholders will consider proposals regarding worker rights assessment, director re-nomination criteria, policies on golden parachutes, and director time allocation disclosure. The board recommends voting for the election of all director nominees and most proposals but advises against proposals related to worker rights assessment, director re-nomination, golden parachutes, and director time allocation disclosure. Stockholders can access meeting materials and vote online at www.ProxyVote.com, with options to request paper or email copies of the materials by May 2, 2024.
CVS Health Corporation宣佈了其2024年年度股東大會,該會議定於2024年5月16日虛擬舉行。鼓勵股東在會議之前投票,投票截止日期定爲美國東部時間2024年5月15日晚上 11:59。會議將討論幾項關鍵提案,包括董事選舉、批准2024年獨立註冊會計師事務所、高管薪酬的諮詢批准以及激勵性薪酬計劃的修訂。此外,股東將考慮有關工人權利評估、董事重新提名標準、黃金降落傘政策以及董事時間分配披露的提案。董事會建議投票選舉所有董事候選人和大部分提案,但建議不要提出與工人權利評估、董事重新提名、黃金降落傘和董事時間分配披露有關的提案。股東可以在www.proxyVote.com上訪問會議材料並在線投票,也可以選擇在2024年5月2日之前索取材料的紙質副本或通過電子郵件發送材料副本。
CVS Health Corporation宣佈了其2024年年度股東大會,該會議定於2024年5月16日虛擬舉行。鼓勵股東在會議之前投票,投票截止日期定爲美國東部時間2024年5月15日晚上 11:59。會議將討論幾項關鍵提案,包括董事選舉、批准2024年獨立註冊會計師事務所、高管薪酬的諮詢批准以及激勵性薪酬計劃的修訂。此外,股東將考慮有關工人權利評估、董事重新提名標準、黃金降落傘政策以及董事時間分配披露的提案。董事會建議投票選舉所有董事候選人和大部分提案,但建議不要提出與工人權利評估、董事重新提名、黃金降落傘和董事時間分配披露有關的提案。股東可以在www.proxyVote.com上訪問會議材料並在線投票,也可以選擇在2024年5月2日之前索取材料的紙質副本或通過電子郵件發送材料副本。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。